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ABSTRACT
Objective: To assess the effect of coding quality on
estimates of the incidence of diabetes in the UK
between 1995 and 2014.
Design: A cross-sectional analysis examining diabetes
coding from 1995 to 2014 and how the choice of
codes (diagnosis codes vs codes which suggest
diagnosis) and quality of coding affect estimated
incidence.
Setting: Routine primary care data from 684 practices
contributing to the UK Clinical Practice Research Datalink
(data contributed from Vision (INPS) practices).
Main outcome measure: Incidence rates of diabetes
and how they are affected by (1) GP coding and (2)
excluding ‘poor’ quality practices with at least 10%
incident patients inaccurately coded between 2004 and
2014.
Results: Incidence rates and accuracy of coding varied
widely between practices and the trends differed
according to selected category of code. If diagnosis
codes were used, the incidence of type 2 increased
sharply until 2004 (when the UK Quality Outcomes
Framework was introduced), and then flattened off, until
2009, after which they decreased. If non-diagnosis codes
were included, the numbers continued to increase until
2012. Although coding quality improved over time, 15%
of the 666 practices that contributed data between 2004
and 2014 were labelled ‘poor’ quality. When these
practices were dropped from the analyses, the downward
trend in the incidence of type 2 after 2009 became less
marked and incidence rates were higher.
Conclusions: In contrast to some previous reports,
diabetes incidence (based on diagnostic codes) appears
not to have increased since 2004 in the UK. Choice of
codes can make a significant difference to incidence
estimates, as can quality of recording. Codes and data
quality should be checked when assessing incidence
rates using GP data.
INTRODUCTION
Although results of analyses are only as good
as the data that they are based on, the effect
of data quality on the results of health
research studies is seldom quantiﬁed, par-
ticularly if there is no gold standard measure
to validate the results.
Clinical Practice Research Datalink
(CPRD) primary care electronic healthcare
records (EHR) span events, including diag-
noses, symptoms, test results, prescriptions
and patient history, and are coded using the
hierarchical system of Read Codes, the stand-
ard clinical terminology system for General
Practice in the UK. Such data provide a lon-
gitudinal picture of patient care over time
and can be used to improve patient care dir-
ectly through effective monitoring and iden-
tiﬁcation of care requirements, and
indirectly via clinical and service-model
research.1
We recently carried out an extensive investi-
gation of code use in the CPRD primary care
database and have developed an approach for
measuring data quality in EHR databases
which can be tailored to the intended use of
the data.2 3 The approach is based on six key
characteristics (dimensions) of good quality
data: accuracy, validity, reliability, timeliness,
relevance and completeness. After identifying
Strengths and limitations of this study
▪ First study to investigate the effects of GP coding
practices on the incidence of diabetes in the UK.
▪ Findings based on a large primary care database
representative of the UK population.
▪ Investigates the effect of coding on recorded
incidence rates since 1995.
▪ No external source of data to verify our findings
since most official statistics on diabetes are
based on GP records.
▪ Algorithms to label misclassified patients pos-
sibly imperfect.
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the most important variables needed for the study in
question (based on the study protocol), data quality mea-
sures are extracted for each relevant dimension.
The database known as CPRD GOLD contains data
from GP practices using Vision software. Recently, CPRD
has started collecting data from practices using EMIS GP
software in addition to Vision. Here, we looked at data
from practices using the Vision software only. We
extracted measures representing different dimensions of
data quality, including missing data and completeness of
the codes used, and discovered that these measures vary
widely between and within practices and over time. We
concluded that data quality characterisation requires a
ﬂexible study-speciﬁc approach that takes into account
the research questions being posed and the types of
data that will be used to answer them.
The next step is to determine how poor data quality
impacts results, using case studies. Most research studies
and ofﬁcial statistics using GP records are based on
coded data, so in this paper, we focus our investigation
on the quality of coding. We examine how the use of
Read codes to record a diagnosis of diabetes has
changed between 1995 and 2014 and how miscoding
and misclassiﬁcation affect incidence estimates between
2004 and 2014.
Diabetes is a growing problem worldwide and is the
subject of many epidemiological and pharmacological
studies. However, these studies may be undermined if
there are variations in recording of the routine data
which are used to study the disease.4 5 This may also
affect treatment choices, risk management and informa-
tion sharing between primary and secondary care set-
tings. Furthermore, the combination of miscoding (an
incorrect or vague Read code applied in patient record)
and misclassiﬁcation (incorrect classiﬁcation of a
patient’s diabetes type) may undermine measures of the
quality of care based on routine data.4 We chose to
measure incidence as it is relatively simple to calculate
and therefore possible to gauge the effects of poor data
quality and also because very few studies have investi-
gated the trends in incidence of diabetes in recent
years,6 and there is some conﬂicting evidence in those
that have.7–9 Statistics on the incidence of diabetes are
very sparse, and most bodies only publish prevalence
ﬁgures, including Diabetes UK.10
Problems with miscoding and misclassiﬁcation of dia-
betes are well known,11 especially before 2004 when the
UK Quality and Outcomes Framework (QoF) was intro-
duced;12 a scheme whereby GPs are partly funded
through the achievement of targets. QoF has been
found to inﬂuence clinicians’ code selection and, in
some illnesses, quality of care.13 Diabetes was ﬁrst
included in QoF in 2004 when codes beginning with
C10 were used to identify patients with diabetes.
According to the Read code system, diagnoses codes
start with capital letters with codes pertaining to a dia-
betes diagnoses using the letter C as the starting letter.
In 2006, a reﬁnement to QoF deﬁnitions required type
to be included (C10E0 to C10EP for type 1 and C10F0
to C10EQ for type 2). Researchers have tried to deal
with miscoding, such as non-speciﬁed diabetes type, and
misclassiﬁcation of type 1 and type 2 diabetes, via a wide
range of methods, including incorporating treatment
and prescription history.7 14 15 However, as far as we are
aware, no one has assessed the effect of miscoding and
misclassiﬁcation on incidence rates obtained from EHR
data.
This study has two parts. In the ﬁrst, we investigate the
recorded incidence of type 1 and type 2 diabetes accord-
ing to different categories of Read codes. In the second,
we assess how dropping practices with over 10% of
patients misclassiﬁed or miscoded between 2004 and
2014 impacts estimates of the incidence rate of type 2
diabetes. We selected type 2 for this part of the analysis
as the incidence is much higher than that of type 1,
and, in contrast to type 1, appears to have been increas-
ing in recent years.
METHODS
The effect of quality and trends in coding was assessed
by:
1. Construction of a hierarchical code list for identifying
diabetes patients and a broader list of indicator codes
for patients that may have diabetes.
2. Calculation of the incidence rate for each year for
each category of codes for all practices contributing
to the CPRD primary care database for each year
between 1995 and 2014.
3. Investigation of the distributions of incidence rates in
the different categories over time.
4. Determination of the effect of variation in coding
quality for diabetes by labelling GP practices as
‘good’ or ‘poor’ quality using an algorithm proposed
and validated by de Lusignan et al,11 which uses diag-
nosis codes, prescribing information and information
from tests to identify cases that are misclassiﬁed or
miscoded.
Developing the code list
All potential Read codes for diabetes were identiﬁed
and divided into four categories. The code list was
created iteratively, using Stata code. A string matching
approach was used to ﬁnd Read terms mentioning dia-
betes and its type. Type 1 was deﬁned as ‘Type 1’ or
insulin-dependent diabetes; Type 2 as ‘Type 2’ or
non-insulin-dependent. These Read terms were manu-
ally inspected and the program was adapted to exclude
terms such as fh: diabetes (fh=family history), gesta-
tional diabetes, diabetes monitoring and other similar
ambiguous terms. The list was then merged with a
CPRD-provided code list used in a recent study and
examined. Relevant Read terms mentioning diabetes
(but not those only mentioning glucose levels) that had
been missed were added to the list. The Read terms and
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associated Read codes were then grouped into categor-
ies. The code list takes this format
Code Description Category
Where category is
1. Type 1 with a diagnostic (C) code
2. Type 2 with a diagnostic (C) code
3. General C code—type not speciﬁed
4. No C code, but code suggests a diagnosis of diabetes
(eg, ‘Diabetes mellitus with unspeciﬁed complica-
tion’. ‘Seen in diabetic clinic’) or diabetes is strongly
implied (eg, ‘Cellulitis in diabetic foot’, ‘Diabetic
nephropathy’)
The codes and categories are provided in the online
supplementary material.
Data
All 684 practices (of the March 2015 version of CPRD)
that have contributed data to the CPRD using the Vision
EHR software on or after 1995 were included in the
study. This included practices for which the CPRD
practice-based quality marker, the Up-to-Standard (UTS)
date indicating when a practice is considered to have
continuous and complete recording of patient data, was
later than 1995. Patients who were not permanently
registered with the GP practice (eg, patients using tem-
porary resident services) were excluded.
Measuring incidence
The code list was used to ﬁnd all clinical, referral and
test type records with a matching code and, for each
patient, the ﬁrst event date in each of the four categor-
ies, plus the Read code issued, was extracted. The ﬁrst
event date (independent of category) was set as the
patient’s index date. Each patient was then classiﬁed
according to the minimum category in the above list. So,
for example, if a patient had a code for category 1 they
are classiﬁed as category 1, even if they also have a code
for type 2—with the index date being the earliest date
that type 2 or type 1 was recorded. A patient with only a
code for category 4 would be classiﬁed as category 4,
etc. The incidence of diabetes, according to each cat-
egory for each year, was evaluated by determining the
number of patients classiﬁed in each category, or com-
bination of categories (for total incidence) and dividing
this by the total person months for that year. Cases with
<365 days between index date and their current registra-
tion were excluded, as they are likely to have been diag-
nosed with diabetes prior to registration.
Assessing the effect of misclassification and miscoding on
incidence of type 2 diabetes
Practices were labelled as either ‘good’ or ‘poor’ quality
for diabetes coding and the impact on incidence of
excluding ‘poor’ practices was assessed. Misclassiﬁed
and miscoded patients and patients apparently
misdiagnosed as either having diabetes or not were
identiﬁed using an algorithm proposed by de Lusignan
et al
11 which uses prescribing information and test
results to query the validity of the application of dia-
betes C codes (note we consider only categories 1–3
here). Practices are deﬁned as ‘poor’ if they have at
least 10% cases ﬂagged as problematic, according to
the algorithm, between 2004 (when the Quality
Outcomes Framework (QoF) incentives for diabetes
coding were introduced) and 2014. Problematic cases
were identiﬁed as follows:
1. Misclassiﬁcation of type 1 diabetes (patient should be
classiﬁed as type 2)
▸ Patients with a diagnosis of type 1 diabetes who
have never been prescribed insulin
▸ Patients with a diagnosis of type 1 diabetes pre-
scribed insulin and an oral antidiabetic medicine
(excluding metformin) prescribed later than
insulin. Patients with type 1 diabetes should not
routinely be concurrently prescribed an oral anti-
diabetic medicine, an exception being metformin
for weight loss
▸ Patients with a diagnosis of type 1 diabetes pre-
scribed insulin and an oral antidiabetic medicine
(excluding metformin) where the oral medicine
was prescribed prior to insulin and insulin is not
prescribed within 6 months of diagnosis. Patients
with type 1 diabetes who started their oral antidia-
betic medicine before insulin should have started
insulin within 6 months of diagnosis
2. Misclassiﬁcation of type 2 diabetes (patient should be
classiﬁed as type 1)
▸ Patients with a diagnosis of type 2 diabetes (that is,
patient whose has a code for type 2, but no code
for type 1 (minimum category as deﬁned in the
section on measuring incidence).) who have been
prescribed insulin within 6 months of diagnosis.
3. Misdiagnosis of type 2 diabetes (patient should not
have a diabetes diagnosis)
▸ Patients with a diagnosis of type 2 diabetes with
none of the following: a prescription for insulin, a
prescription for oral antidiabetic medicine
(excluding metformin), an abnormal plasma
glucose test (≤7.0 mmol/L), an abnormal HbA1c
test (≤48 mmol/mol)
4. Non-diagnosis of type 2 diabetes (false negatives)
▸ Patients prescribed an oral antidiabetic medicine
(excluding metformin) but who do not have a
diagnosis of diabetes.
5. Miscoding in diabetes
▸ Patients with vague diagnosis codes only (eg,
C100z ‘Diabetes without mention of complica-
tions’), which inform the patient has diabetes but
where type cannot be classiﬁed. This is considered
category 3 in our classiﬁcation above.
Only patients with at least 6 months follow-up after
diagnosis were checked for the last item in part 1 and
for part 2. We calculated the proportion of patients with
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problematic coding as the proportion of all patients with
a C code plus false-negative patients with ﬁrst diagnosis
(or misdiagnosis code) between 2004 and 2014.
Statistical analysis
Statistical analyses were performed with Stata V.13 (Stata
Corp. 2013. Stata Statistical Software: Release 13. College
Station, Texas, USA: StataCorp LP). Descriptive
summary statistics and visualisation methods were used
to investigate different coding and trends in incidence.
Overall percentages, means and medians for each year
were calculated using the Stata ‘collapse’ command. To
investigate the effect of poor data quality on the inci-
dence rate, we estimated the incidence for each year, as
deﬁned by QOF (ie, diabetes diagnosis codes with type
included) for ‘good’ and ‘poor quality’ practices separ-
ately. A linear regression model was used to determine if
the differences in incidence rates for ‘good’ and ‘bad’
practices were statistically signiﬁcant. Non-linear terms
for year and an interaction between group and year
were included in the model, which was adjusted for
repeated measures (for practices) using the Stata
‘cluster’ command. A non-parametric trend test was
used to ascertain the signiﬁcance level of the trend in
overall incidence in (1) the whole population and (2)
the subset of the population which excludes ‘poor’
practices.
Analytic weights (Stata’s aweights) were used for all
practice-based analyses to adjust for the practice size.
RESULTS
Four hundred and eleven of the 684 practices contribu-
ted data continuously from 1 January 1995 to the end of
December 2014. The median number of patients per
practice increased by 37% in this period and the
number of patients with an incident code more than
doubled (table 1).
Read code use
Table 2 shows the change in code usage between 1995
and 2004. In 1995 and 2004, the most commonly used
Read term was ‘Type 2 diabetes mellitus’ (Read code
C10F); the second most common was ‘Diabetes mellitus’
(Read code C10) in 1995 and ‘Seen in diabetes clinic’
(Read code 9N1Q) in 2014. Within each category, there
was little variation in code use in each year, with the top
three codes representing at least 69% of codes extracted
in 1995 and 90% of codes extracted in 2014.
Practice variation
Incidence rates varied widely between practices for each
category (ﬁgure 1), particularly for category 2 (type 2)
and category 4 (diabetes inferred). There was a relatively
large number of outlying practices which had a much
higher rates, including some not shown in the ﬁgure,
with incidence rates of over 2000 per 100 000 in some
years (which might be due to incorrect dates if records
were added retrospectively). Variation between practices
(as indicated by the relative sizes of the boxes) increased
markedly for category 4 between 2005 and 2009.
In order to see if we could explain the large increase
in variation (and also incidence) in category 4 after
2005, we split category 4 into two subcategories: 4a and
4b. Subcategory 4b contained codes with ‘seen’ in the
Read term, for example, ‘seen in diabetes clinic’ or
‘seen by diabetic nurse’. Although suggestive of a dia-
betes diagnosis, they could also indicate monitoring of
patients at risk of diabetes.
Overall incidence in each category
Table 3 shows the overall incidence rates over time for
each of the four categories, with category 4 split into 4a
and 4b. For those patients with a diagnosis code, the
incidence of type 1 diagnosis increased from 1995 to
2000 but then decreased quite steeply from 2001 to
2014. Conversely, for type 2, the incidence increased
from 1995 to 2004 after which it levelled off and slightly
decreased between 2010 and 2014. Category 3 (C code
no type) shows a decrease until 2006 when it then levels
off and increases slightly again after 2011. For category
4, where there was no diagnosis code, the large increase
after 2006 was accounted for by the large increase in
‘seen in diabetic clinic’ code.
In order to see if we could explain the decrease in inci-
dence of type 1, we investigated cases who had a diagnosis
of type 1 and type 2 diabetes, but who were classiﬁed as
type 1 by our algorithm. Almost 40% of type 1 with a ﬁrst
diagnosis in 1995 were in this category, but this percent-
age decreased almost linearly with year to <10% in 2014.
When these cases were excluded, the incidence (per
100 000) in 1995 (12.1) was similar to that in 2012 (12.3)
with a slight decrease in 2013 (11.2) and 2014 (10.5).
Removing codes in category 4b had a big effect on the
incidence rates of category 4 and also of all categories
combined (ﬁgure 2). When these codes are included,
the incidence (using all codes) increases until 2009 to
nearly 600 per 100 000 before levelling off, whereas
when they are excluded, the incidence levels off at just
under 400 per 100 000 after 2004.
Table 1 Summary statistics for number of practices that
contributed data (for at least part of the year) and patients
in 1995 and 2014
Year
Statistic 1995 2014
Number (N) contributing practices* 677 498
Person years 3.8
million
3.8
million
Median N of patients per practice 5269 7223
Total N with first diabetes code
during year
8314 18 151
*Changes in market distribution of practice software use have
seen a decline in Vision practices during 2014. CPRD has
collected data from EMIS practices which offsets the loss;
however, this analysis is in Vision practices only.
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Effect of misclassification and miscoding on incidence of
type 2 diabetes
Rates of misclassiﬁcation and miscoding varied widely
between practices, but variation and error rates gener-
ally decreased over time (ﬁgure 3). The overall
number of patients miscoded, misclassiﬁed or misdiag-
nosed (in categories 1–3) per 100 000 halved from 60
in 1994 to 30 in 2014. Of the 666 practices that con-
tributed data for at least some point between 2004 and
2014, 102 (15%) had at least 10% of their diagnosed
diabetes patients misclassiﬁed or miscoded during
this period. The number of patients misclassiﬁed
(categories 1–4) per 100 000 halved from 60 in 1994 to
30 in 2014.
Table 2 The three most commonly extracted Read terms in 1995 and 2014 for (1) any category and (2) for each category 1–4
Year
1995 2014
Category Read term
Read
code No.
Per
cent Read term
Read
code No.
Per
cent
Any Type 2 diabetes mellitus C10F.00 2559 31 Type 2 diabetes mellitus C10F.00 10 017 55
Diabetes mellitus C10.00 2046 25 Seen in diabetic clinic 9N1Q.00 5727 32
Non-insulin-dependent
diabetes mellitus
C109.00 1702 20 Diabetes mellitus C10.00 753 4
1 Insulin-dependent diabetes
mellitus
C100011 484 59 Type 1 diabetes mellitus C108.12 361 90
Type 1 diabetes mellitus C108.12 256 31 Insulin-dependent
diabetes mellitus
C100011 18 4
IDDM-insulin-dependent
diabetes mellitus
C108.11 38 5 Type 1 diabetes mellitus
with ketoacidosis
C10EM00 12 3
2 Type 2 diabetes mellitus C10F.00 2559 53 Type 2 diabetes mellitus C10F.00 10 017 97
Non-insulin-dependent
diabetes mellitus
C109.00 1702 35 Non-insulin-dependent
diabetes mellitus
C109.00 137 1
Maturity onset diabetes C100111 421 9 Type II diabetes mellitus C10F.11 58 1
3 Diabetes mellitus C10.00 2046 97 Diabetes mellitus C10.00 753 97
Diabetes mellitus, adult
onset, no mention of
complication
C100100 52 2 Secondary diabetes
mellitus
C10N.00 7 1
Diabetes mellitus with no
mention of complication
C100.00 12 1 Cystic fibrosis-related
diabetes mellitus
C10N100 3 0
4 Attending diabetes clinic 9NM0.00 153 29 Seen in diabetic clinic 9N1Q.00 5727 86
H/O: diabetes mellitus 1434 139 26 O/E—Right diabetic foot
at low risk
2G5E.00 172 3
Seen in diabetic clinic 9N1Q.00 75 14 Diabetic annual review 66AS.00 128 2
Each patient is counted only once and the Read term is the earliest to be recorded in the patient’s assigned category.
Figure 1 Distribution of the
practice incidence of diabetes per
100 000 according to the different
code categories between 1995
and 2014. Some very extreme
values ( >1000) have been
removed for clarity of
presentation.
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How dropping ‘poor’ quality practices affects type 2
diabetes incidence rates
‘Poor’ practices had a lower incidence than ‘good’ prac-
tices with a steeper downward trend (from 340/100 000
in 2004 to 245/100 000 in 2014).
The regression model conﬁrmed that incidence is sig-
niﬁcantly lower (p=0.001) for ‘poor’ practices than ‘good’.
Incidence decreased linearly with year (p≤0.001) between
2004 and 2014 (non-linear terms for year were not signiﬁ-
cant). Adding an interaction term between year and type
of practice indicated that the rate of decrease differed sig-
niﬁcantly between the two groups (p=0.005).
A trend test of the overall incidence of diabetes type 2
with year between 2004 and 2014 was signiﬁcant at the
0.05 level for ‘all’ (p=0.035) but not signiﬁcant at this
level for ‘good’ practices (p=0.096).
These results show that including practices with poor
quality recording can affect the incidence rates and
trends and may lead to different conclusions. If poor
quality practices are excluded, incidence rates are
higher and the evidence for a downward trend in inci-
dence is weaker.
DISCUSSION
This study, based on a large database of GP records,
shows that the choice of Read codes used to deﬁne a
diagnosis of diabetes can make a big difference to
Table 3 Incidence rates per 100 000 between 1995 and 2014 for the different code categories
Code category
Year 1 (type 1) 2 (type 2) 3 (no type)
4a (suggested,
not ‘seen in’)
4b (suggested,
‘seen in’)
1995 21.4 126.7 55.3 11.9 2.1
1995 21.4 126.7 55.3 11.9 2.1
1996 22.7 145.0 59.9 8.6 2.8
1997 22.3 150.8 50.9 7.8 3.8
1998 20.8 167.9 47.5 6.5 3.6
1999 22.1 199.5 45.6 6.1 4.1
2000 24.5 256.9 45.2 5.9 6.1
2001 24.1 293.4 41.5 6.5 7.7
2002 20.8 323.0 33.3 8.0 7.8
2003 19.0 332.2 22.1 11.9 8.9
2004 19.1 359.9 18.8 15.7 16.3
2005 17.1 354.2 11.9 16.1 16.5
2006 15.4 341.4 5.6 17.9 32.2
2007 15.1 345.8 6.8 17.1 100.7
2008 14.9 351.2 5.2 12.4 153.3
2009 15.0 358.8 5.3 14.5 198.4
2010 14.9 350.4 6.5 14.9 183.0
2011 14.2 327.9 6.9 19.6 173.3
2012 14.4 331.4 10.0 19.5 186.3
2013 12.9 334.8 16.2 22.3 186.7
2014 11.3 284.9 20.7 25.0 163.6
Figure 2 Incidence of diabetes per 100 000 between 1990 and 2013 for (A) all codes and (B) all codes excluding codes with
the word ‘seen’ in the code description.
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incidence estimates. If diagnosis codes alone are used,
the incidence of diabetes cases per 100 000 in the UK
appears to have increased between 1995 and 2002,
peaking at just below 400 in 2004 and slightly decreasing
since then. However, if non-diagnostic codes are
included, rates appear to have increased sharply from
just above 400 in 2006 to just under 600 in 2009 and
remained at over 500 thereafter.
The results based on diagnosis codes conﬁrm other
reports that diabetes incidence has not increased in
recent years in developed countries,6 including a recent
report from the UK.16 The results using the broader
Read code list mirror those obtained by Holden et al7
who observed a similar large increase in type 2 diabetes
from 2006 to 2009. The increase in the number of
patients with suggested diabetes after 2006 appears to be
due to the greatly increased use of the code ‘seen in dia-
betes clinic’. This is in line with the large increase in the
incidence of ‘pre-diabetes’.9
The choice of practices to include in the analysis also
affects the incidence estimates of type 2 diabetes. Our
analysis shows that including ‘poor’ quality practices may
lead to erroneous conclusions about incidence rate and
trends. There is a high level of variability between prac-
tices in miscoding/misclassiﬁcation rates and, even since
QOF was introduced, many practices still use indetermin-
ate codes, which, while they almost disappeared after the
case deﬁnition for diabetes was changed in 2006 (see
below), have been creeping up again in recent years. The
usefulness and accuracy (quality) of codes also depends
on the team entering them,17 the clinicians’ IT skills,18
time,19 certainty of diagnosis,20 how important they
believe coding is20 and organisational issues.20
There is also large variation between practices in the
recorded number of patients with a diagnosis code each
year, with some practices having a much higher inci-
dence than others. This may be partly due to incorrect
dates—for example, we noticed that some practices had
large spikes in new diabetes patients on certain dates,
which might be due to retrospectively entering the code
with the incorrect date.
The decrease in incidence in category 1 (type 1) was
found to be due to better coding in more recent years,
with an inﬂated incidence in earlier years due to mis-
coding type 2 cases as type 1.
Strengths and limitations
This is the ﬁrst study to investigate the effects of GP
coding practices on incidence rates of diabetes in the
UK, using a large primary care database, which is repre-
sentative of the UK population. Our ﬁndings show the
importance of investigating and identifying poor coding
when making conclusions based on GP records. A limita-
tion of this study is that there is no external source of
data to verify our ﬁndings since (a) most authorities on
diabetes (eg, Diabetes UK) only publish prevalence rates
and (b) most ofﬁcial statistics on diabetes are based on
Read codes in GP records, so any external validation
would be self-referencing. Since it was not possible to
verify the status of individual patients, we had to use pos-
sibly imperfect algorithms to label misclassiﬁed patients,
which will inevitably mean that we will have mislabelled
some patient records, for example, if a therapy prescrip-
tion is made during a hospital visit, this patient would
be misclassiﬁed by our algorithm. However, we suggest
that this would be infrequent and would not affect our
overall ﬁndings.
Implications
Our research has identiﬁed the impact of miscoding
and misclassiﬁcation on the recorded incidence of dia-
betes. It is likely that similar trends, errors and variations
exist for other conditions, potentially more so where
coding is not incentivised. A number of developments
Figure 3 Distribution of patients
per practice with incorrect
diabetes coding according to de
Lusignan algorithm. (Some very
extreme values have been
removed for clarity of
presentation.) Categories: (1)
misclassification of type 1, (2)
misclassification 2, (3)
misclassification of type 2 (false
positives) and (4) non-diagnosis
of type 2 (false negatives).
(Category 5 is not shown as it is
the same as Read codes
category 3).
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have been implemented or are intended on a national
scale that may impact on this in future.
The last release of V2 Read codes took place in April
2016 and the ﬁnal release of CTV3 is planned for April
2018. This will herald the transition to SNOMED-CT.21
While this will allow more precise coding, it risks over-
whelming practitioners with choice due to its broader
dictionary of terms. To improve the quality of database
research, we must focus on improvements in data entry
at the point of care. Understanding how data are
recorded and used in general practice was introduced as
a core competency in the 2016 RCGP training curricu-
lum.22 Although trainees make up a signiﬁcant propor-
tion of the workforce, the bulk of EHR data entry is
performed by qualiﬁed GPs. Previous experience with
QoF13 suggests that data quality can be improved
through ﬁnancial incentives. The expansion of quality
indicators across wider clinical conditions could provide
an improvement in data quality; however, further targets
may not be readily embraced by the workforce at this
time.
Alternatively, software improvements to present the
practitioner with preferred terms could provide signiﬁ-
cant improvements in data entry and are more in line
with ‘nudge’ techniques used in population health.23 In
the meantime, research of large primary care data sets
should ensure that code lists are optimised to account for
recording variations and, where possible, be validated
against real clinical practice. Reporting error measure-
ments to account for miscoding and misclassiﬁcation
should be included in future studies to provide a truer
presentation of results.
CONCLUSION
Our aim was to assess the effect of poor data quality
around term selection by GP on results. For this case
study, we picked diabetes incidence as a computationally
simple example which, despite being straightforward to
calculate, is not very often reported due to the difﬁculty
of pinpointing the exact date of disease diagnosis. We
found that the choice of code list made a huge differ-
ence to the results, and the incidence was inﬂated when
we included Read codes which suggested monitoring of
possible diabetes, rather than a diagnosis itself. We
suggest that if these codes are to be included as indica-
tion of diagnosis, the diagnosis should be conﬁrmed
with test results and prescribing information as was per-
formed by Sadek et al14 for diagnosis codes.
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